| Name |
Sandostatin LAR 30 mg prašak i otapalo za suspenziju za injekciju |
| Marketing Authorisation Number |
HR-H-983646054 |
| Active Substance |
oktreotidacetat |
| Composition |
jedna bočica sadrži 30 mg oktreotida (u obliku oktreotidacetata) |
| Pharmaceutical Form |
prašak i otapalo za suspenziju za injekciju |
| Manufacturer |
Novartis Farmacéutica S.A., Barcelona, Španjolska |
| Marketing Authorisation Holder |
Novartis Hrvatska d.o.o., Radnička cesta 37b, Zagreb, Hrvatska |
| Marketing Authorisation Date |
13.03.2019 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/19-02/14 |
| Registration Number |
381-12-01/70-19-02 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product subject to restricted medical prescription
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
H01CB02 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
